DK0798378T3 - Estrogen-receptor - Google Patents

Estrogen-receptor

Info

Publication number: DK0798378T3
Authority: DK; Denmark
Prior art keywords: estrogen receptor; receptors; relates; present; dna encoding
Prior art date: 1996-03-26

Application number

DK97200903T

Other languages

Danish (da)

English (en)

Inventor

Sietse Mosselman

Rein Dijkema

Original Assignee

Akzo Nobel Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-03-26

Filing date

1997-03-25

Publication date

2002-04-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26142641&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0798378(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-03-25 Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv

2002-04-29 Application granted granted Critical

2002-04-29 Publication of DK0798378T3 publication Critical patent/DK0798378T3/da

Links

102000015694 estrogen receptors Human genes 0.000 title 1
108010038795 estrogen receptors Proteins 0.000 title 1
108700010039 chimeric receptor Proteins 0.000 abstract 1
108020003175 receptors Proteins 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C12N15/72—Expression systems using regulatory sequences derived from the lac-operon
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/723—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Biomedical Technology (AREA)
Physics & Mathematics (AREA)
Toxicology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Cell Biology (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Plant Pathology (AREA)
High Energy & Nuclear Physics (AREA)
Endocrinology (AREA)
Peptides Or Proteins (AREA)
Steroid Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Investigating Or Analysing Biological Materials (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Measuring And Recording Apparatus For Diagnosis (AREA)
Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)

DK97200903T 1996-03-26 1997-03-25 Estrogen-receptor DK0798378T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP96200820		1996-03-26
EP96203284		1996-11-11

Publications (1)

Publication Number	Publication Date
DK0798378T3 true DK0798378T3 (da)	2002-04-29

Family

ID=26142641

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97200903T DK0798378T3 (da)	1996-03-26	1997-03-25	Estrogen-receptor

Country Status (12)

Country	Link
US (3)	US7060490B1 (fr)
EP (2)	EP0798378B1 (fr)
JP (1)	JPH104986A (fr)
KR (1)	KR19980041692A (fr)
AT (1)	ATE212055T1 (fr)
AU (1)	AU715812B2 (fr)
CA (1)	CA2200423C (fr)
DE (2)	DE69709561T2 (fr)
DK (1)	DK0798378T3 (fr)
ES (1)	ES2123482T3 (fr)
GR (1)	GR980300076T1 (fr)
HU (1)	HU221411B1 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE792292T1 (de) *	1995-09-08	1998-09-03	Karo Bio Ab, Huddinge	Waisen-rezeptor
US7157568B1 (en) *	1997-08-05	2007-01-02	American Home Products Corporation	Human estrogen receptor-β
ATE335820T1 (de) *	1997-09-08	2006-09-15	Merck & Co Inc	Östrogenrezeptor
US6222015B1 (en)	1997-09-08	2001-04-24	Merck & Co., Inc.	Estrogen receptor
DE19839115A1 (de) *	1998-08-27	2000-03-09	Ihf Inst Fuer Hormon Und Fortp	Klonierung und Expression von Rinder Estrogenrezeptor-beta
DE19855013C2 (de)	1998-11-20	2001-09-13	Schering Ag	Androgen- und Progesteron-Rezeptor bindendes Hormon Response Element
WO2000031112A1 (fr)	1998-11-20	2000-06-02	Akzo Nobel N.V.	Estra-1,3,5(10)-trienes a chaine hydrocarbure lineaire de 5-9 atomes de c en position 11, ayant des effets differentiels sur les recepteurs alpha et beta des oestrogenes
US6756366B1 (en) *	1999-04-06	2004-06-29	Akzo Nobel N.V.	Orally active androgens
US7214706B2 (en)	2000-03-01	2007-05-08	Akzo Nobel N.V.	Chroman derivatives as estrogenic compounds
CN1304578C (zh)	2000-03-22	2007-03-14	罗姆和哈斯公司	新的基于蜕皮激素受体的可诱导的基因表达系统
US20040033600A1 (en)	2001-03-21	2004-02-19	Palli Subba Reddy	Ecdysone receptor-based inducible gene expression system
TWI225068B (en)	2000-06-06	2004-12-11	Akzo Nobel Nv	Anellated steroid compounds having contraceptive and anti-osteoporosis activity
US8105825B2 (en)	2000-10-03	2012-01-31	Intrexon Corporation	Multiple inducible gene regulation system
EP1373470B1 (fr)	2001-02-20	2013-04-24	Intrexon Corporation	Nouveaux recepteurs de mutants de substitution et utilisation de ceux-ci dans un systeme d'expression genique inductible a base de recepteurs nucleaires
ES2424812T3 (es)	2001-02-20	2013-10-08	Intrexon Corporation	Receptores X retinoides quiméricos y su uso en un sistema inducible de expresión génica basado en receptores de ecdisona novedoso
EP1534738B1 (fr)	2001-02-20	2012-06-20	Intrexon Corporation	Nouveaux recepteurs a mutant de substitution et utilisation de ceux-ci dans un systeme d'expression de gene inductible fonde sur un recepteur nucleaire
AU2002247184B2 (en)	2001-02-20	2008-06-19	Intrexon Corporation	Novel ecdysone receptor/invertebrate retinoid X receptor-based inducible gene expression system
EP1288303A1 (fr) *	2001-08-23	2003-03-05	Aventis Pharma S.A.	Systèmes d'expression inductibles utilisant PPAR comme activateurs transcriptionnels
WO2003012113A2 (fr) *	2001-08-02	2003-02-13	Gencell S.A.	Systemes d'expression inductibles utilisant des activateurs transcriptionnels ppar
US7563879B2 (en)	2001-09-26	2009-07-21	Intrexon Corporation	Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof
AU2002327787A1 (en) *	2001-09-28	2003-04-07	Gordon L. Hager	Glucocorticoid receptor nuclear translocation domain
TW200304371A (en)	2002-02-22	2003-10-01	Akzo Nobel Nv	Substituted 10-ary1-11H-benzo [b] fluorenes and 7-ary1-5, 6-dihydro-benz [a] anthracenes for selective effects on estrogen receptors
US7674783B2 (en)	2002-11-22	2010-03-09	Dimera Inc.	Estrogen beta receptor agonists to prevent or reduce the severity of cardiovascular disease
US7304161B2 (en)	2003-02-10	2007-12-04	Intrexon Corporation	Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
US7456315B2 (en)	2003-02-28	2008-11-25	Intrexon Corporation	Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
US7935510B2 (en)	2004-04-30	2011-05-03	Intrexon Corporation	Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
UA89964C2 (ru)	2004-09-08	2010-03-25	Н.В. Органон	15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
CN105283439B (zh)	2013-03-15	2018-02-02	英特瑞克斯顿股份有限公司	含硼的二酰基肼类化合物
WO2016044390A1 (fr)	2014-09-17	2016-03-24	Intrexon Corporation	Composés diacylhydrazine contenant du bore

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU7084787A (en) *	1986-02-20	1987-09-09	Karo Bio Ab	Eucaryotic expression of steroid receptor proteins
US5217867A (en) *	1988-11-30	1993-06-08	The Salk Institute For Biological Studies	Receptors: their identification, characterization, preparation and use
FR2649994A1 (fr) *	1989-06-30	1991-01-25	Aderegem	Procede d'obtention d'un recepteur humain natif sauvage des oestrogenes et ses applications
WO1992008133A1 (fr) *	1990-10-29	1992-05-14	Dekalb Plant Genetics	Isolation de materiaux biologiques au moyen de particules magnetiques
ATE215601T1 (de) *	1991-09-17	2002-04-15	Salk Inst For Biological Studi	Rezeptoren der steroid/thyroid superfamilie von rezeptoren
DE792292T1 (de) *	1995-09-08	1998-09-03	Karo Bio Ab, Huddinge	Waisen-rezeptor
US7157568B1 (en) *	1997-08-05	2007-01-02	American Home Products Corporation	Human estrogen receptor-β

1997
- 1997-03-19 CA CA002200423A patent/CA2200423C/fr not_active Expired - Fee Related
- 1997-03-24 HU HU9700636A patent/HU221411B1/hu not_active IP Right Cessation
- 1997-03-25 ES ES97200903T patent/ES2123482T3/es not_active Expired - Lifetime
- 1997-03-25 DK DK97200903T patent/DK0798378T3/da active
- 1997-03-25 KR KR1019970010207A patent/KR19980041692A/ko not_active Ceased
- 1997-03-25 EP EP97200903A patent/EP0798378B1/fr not_active Revoked
- 1997-03-25 DE DE69709561T patent/DE69709561T2/de not_active Revoked
- 1997-03-25 AT AT97200903T patent/ATE212055T1/de not_active IP Right Cessation
- 1997-03-25 EP EP01202021A patent/EP1162264A3/fr not_active Withdrawn
- 1997-03-25 AU AU16521/97A patent/AU715812B2/en not_active Ceased
- 1997-03-25 DE DE0798378T patent/DE798378T1/de active Pending
- 1997-03-26 US US08/826,361 patent/US7060490B1/en not_active Expired - Fee Related
- 1997-03-26 JP JP9074122A patent/JPH104986A/ja not_active Withdrawn
1998
- 1998-11-30 GR GR980300076T patent/GR980300076T1/el unknown
2000
- 2000-06-30 US US09/608,088 patent/US6680368B1/en not_active Expired - Lifetime
- 2000-11-13 US US09/711,288 patent/US6713270B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
GR980300076T1 (en)	1998-11-30
EP0798378A2 (fr)	1997-10-01
DE69709561T2 (de)	2002-08-29
CA2200423C (fr)	2006-12-19
US6713270B1 (en)	2004-03-30
ATE212055T1 (de)	2002-02-15
AU1652197A (en)	1997-10-02
EP1162264A3 (fr)	2002-05-15
ES2123482T3 (es)	2002-11-01
AU715812B2 (en)	2000-02-10
EP1162264A2 (fr)	2001-12-12
JPH104986A (ja)	1998-01-13
HUP9700636A3 (en)	1999-01-28
DE69709561D1 (de)	2002-02-21
HUP9700636A2 (hu)	1998-04-28
ES2123482T1 (es)	1999-01-16
HK1001978A1 (en)	1998-07-24
US7060490B1 (en)	2006-06-13
US6680368B1 (en)	2004-01-20
DE798378T1 (de)	1999-03-04
KR19980041692A (ko)	1998-08-17
EP0798378B1 (fr)	2002-01-16
CA2200423A1 (fr)	1997-09-26
EP0798378A3 (fr)	1997-12-29
HU9700636D0 (en)	1997-05-28
HU221411B1 (en)	2002-09-28

Publication	Publication Date	Title
ATE212055T1 (de)	2002-02-15	Östrogen-rezeptor
HN1997000040A (es)	1997-06-05	Sal mesilatotrihidroto de 5-2-4-1,2 -benzoisotiazol -3 il 1- piperazinil etil -6 - cloro 13 dihidro 2h indol 2-ona.
DE69708120D1 (de)	2001-12-13	Laser-absorbierende, lichtbleichbare zusammensetzungen
GEP20105118B (en)	2010-11-25	Anti-vegf antibodies
FI971262A7 (fi)	1997-03-26	Tehostajat, kuten asetosyringoni
WO2003004529A3 (fr)	2004-06-10	Materiaux de recepteur ephrine-tie et leurs procedes
BR9706717B1 (pt)	2009-01-13	mecanismo de distribuição.
SI1095140T1 (sl)	2012-01-31	Nevrotrofični dejavniki
TR199601002A1 (tr)	1997-08-21	2-Okzo- ve 2-thio-1, 2-dihidrokinolinil-oksazolidinonlar.
DZ2769A1 (fr)	2003-12-01	Composés tricycliques substitués.
CY1107339T1 (el)	2012-12-19	Mu-1, μελος της οικογενειας υποδοχεα κυτοκινης
ZA988676B (en)	1999-12-03	Amino-terminally truncated MCP-2 as chemokine antagonists.
IT1303546B1 (it)	2000-11-14	Cerniera lampo.
FR2721390B1 (fr)	1996-08-14	Manchon anti-arcure.
NO990666D0 (no)	1999-02-12	FremgangsmÕte for diversitets-kombinering, samt mottaker
NL1004470A1 (nl)	1998-05-14	Buis.
DZ2454A1 (fr)	2003-01-18	Plasmides bactériens.
ZA988637B (en)	2000-03-22	Methods for regulating trkA expression.
DE59708914D1 (de)	2003-01-23	Beuteimitierendes, Stückiges Futtermittel
WO2000037634A3 (fr)	2001-01-18	Nouveaux polypeptides et acides nucleiques codant pour ceux-ci
ATE231848T1 (de)	2003-02-15	Substituierte 2-benzoyl-cyclohexan-1,3-dione
AU2001250322A1 (en)	2001-08-27	Novel, central nervous protein, that modulates k+ flows
ES1033403Y (es)	1997-01-01	Encendedor solar ecologico perfeccionado.
ES1038761Y (es)	1999-01-16	Sustentador-unificador de envases tipo botella.
ITCA970019A0 (it)	1997-06-24	Beccuccio.